Published in Ann Thorac Surg on October 01, 2005
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Cell Death Dis (2013) 0.93
Impact of PET-CT on primary staging and response control on multimodal treatment of esophageal cancer. World J Surg (2011) 0.91
Invited commentary. Ann Thorac Surg (2005) 0.75
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol (2003) 2.44
The modern treatment of early gastric cancer: our experience in an Italian cohort. Surg Endosc (2009) 2.23
Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol (2007) 1.93
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg (2009) 1.84
Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg (2013) 1.83
Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol (2006) 1.69
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg (2004) 1.65
Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum. Gastric Cancer (2003) 1.62
Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg (2002) 1.50
Postoperative variation of C-reactive protein and procalcitonin in patients with gastrointestinal cancer. Clin Lab (2009) 1.49
Laparoscopic cholecystectomy for severe acute cholecystitis. A meta-analysis of results. Surg Endosc (2007) 1.48
Treatment for retained [corrected] common bile duct stones during laparoscopic cholecystectomy: the rendezvous technique. Arch Surg (2010) 1.47
Perforated gastric carcinoma: a report of 10 cases and review of the literature. World J Surg Oncol (2006) 1.40
Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol (2010) 1.39
Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg (2012) 1.34
Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol (2002) 1.34
Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg (2007) 1.32
CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions. Am J Surg (2009) 1.31
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery (2006) 1.25
Abdominal-pelvic actinomycosis mimicking malignant neoplasm. Infect Dis Obstet Gynecol (2011) 1.19
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. Gastric Cancer (2012) 1.15
How much remnant is enough in liver resection? Dig Surg (2012) 1.14
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups. Oncotarget (2014) 1.14
Oncogenic mutations in gastric cancer with microsatellite instability. Eur J Cancer (2011) 1.14
MET mutations in cancers of unknown primary origin (CUPs). Hum Mutat (2010) 1.13
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Updates on abdominal desmoid tumors. World J Gastroenterol (2007) 1.09
Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer (2003) 1.07
Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol (2003) 1.06
Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma. Arch Surg (2009) 1.06
Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology (2003) 1.03
Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg (2007) 1.02
Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg (2006) 1.02
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol (2004) 1.01
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers. Gastric Cancer (2013) 1.00
Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer (1998) 0.99
Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg (2002) 0.98
Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. J Thorac Cardiovasc Surg (2012) 0.98
Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol (2006) 0.98
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. Ann Surg Oncol (2011) 0.97
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer (2010) 0.97
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol (2004) 0.97
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. Br J Haematol (2004) 0.96
p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol (2002) 0.96
3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study. Clin Cancer Res (2007) 0.94
Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol (2007) 0.94
Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Cancer (2003) 0.93
Predictors of recurrence after laparoscopic ventral hernia repair. Surg Laparosc Endosc Percutan Tech (2009) 0.93
Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. Ann Surg (2009) 0.92
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. Gastric Cancer (2006) 0.92
18F-FDG-PET/CT in patients with breast cancer and rising Ca 15-3 with negative conventional imaging: a multicentre study. Eur J Radiol (2010) 0.92
Treatment of gallstone pancreatitis: six-year experience in a single center. World J Surg (2001) 0.91
Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patients. Clin Cancer Res (2011) 0.90
Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg (2007) 0.89
Liver resection for hepatocellular carcinoma ≤3 cm: results of an Italian multicenter study on 588 patients. J Am Coll Surg (2012) 0.89
The Dagradi-Serio-Iacono operation central pancreatectomy. J Gastrointest Surg (2007) 0.89
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. Ann Surg Oncol (2014) 0.88
The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys (2009) 0.88
CDH1 C-160A promoter polymorphism and gastric cancer risk. Eur J Cancer Prev (2009) 0.88
The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer. Pharmacogenomics (2011) 0.88
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. Clin Cancer Res (2014) 0.88
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy. Ann Surg Oncol (2011) 0.88
Perigastric lymph node metastases in gastric cancer: comparison of different staging systems. Gastric Cancer (1999) 0.87
Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol (2010) 0.87
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? J Surg Oncol (2010) 0.86
Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours. Br J Clin Pharmacol (2011) 0.86
hERG1 channels in human esophagus: evidence for their aberrant expression in the malignant progression of Barrett's esophagus. J Cell Physiol (2006) 0.86
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg (2013) 0.86
Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers. Clin Chem Lab Med (2010) 0.85
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? J Surg Oncol (2005) 0.85
CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch (2004) 0.84
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. World J Gastroenterol (2005) 0.83
Additional value of FDG-PET/CT in management of "solitary" liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Biol (2009) 0.83
Routine use of simultaneous laparoendoscopic approach in patients with confirmed gallbladder and bile duct stones: fit for laparoscopy fit for "rendezvous". World J Surg (2013) 0.83
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. PLoS One (2013) 0.82
Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford) (2011) 0.82
Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol (2006) 0.81